Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Regulation of Brain DNA Methylation Factors and of the Orexinergic System by Cocaine and Food Self-Administration.

Saad L, Sartori M, Pol Bodetto S, Romieu P, Kalsbeek A, Zwiller J, Anglard P.

Mol Neurobiol. 2019 Aug;56(8):5315-5331. doi: 10.1007/s12035-018-1453-6. Epub 2019 Jan 2.

PMID:
30603957
2.

Inhibition of DNA methyltransferases regulates cocaine self-administration by rats: a genome-wide DNA methylation study.

Fonteneau M, Filliol D, Anglard P, Befort K, Romieu P, Zwiller J.

Genes Brain Behav. 2017 Mar;16(3):313-327. doi: 10.1111/gbb.12354. Epub 2016 Nov 23.

3.

Differential regulation of MeCP2 and PP1 in passive or voluntary administration of cocaine or food.

Bodetto SP, Romieu P, Sartori M, Tesone-Coelho C, Majchrzak M, Barbelivien A, Zwiller J, Anglard P.

Int J Neuropsychopharmacol. 2014 Dec;17(12):2031-44. doi: 10.1017/S1461145714000972. Epub 2014 Jun 17.

PMID:
24936739
4.

Cocaine represses protein phosphatase-1Cβ through DNA methylation and Methyl-CpG Binding Protein-2 recruitment in adult rat brain.

Pol Bodetto S, Carouge D, Fonteneau M, Dietrich JB, Zwiller J, Anglard P.

Neuropharmacology. 2013 Oct;73:31-40. doi: 10.1016/j.neuropharm.2013.05.005. Epub 2013 May 18.

PMID:
23688924
5.

Histone deacetylase inhibitors upregulate MMP11 gene expression through Sp1/Smad complexes in human colon adenocarcinoma cells.

Barrasa JI, Olmo N, Santiago-Gómez A, Lecona E, Anglard P, Turnay J, Lizarbe MA.

Biochim Biophys Acta. 2012 Feb;1823(2):570-81. doi: 10.1016/j.bbamcr.2011.12.010. Epub 2011 Dec 29.

6.

CDKL5 is a brain MeCP2 target gene regulated by DNA methylation.

Carouge D, Host L, Aunis D, Zwiller J, Anglard P.

Neurobiol Dis. 2010 Jun;38(3):414-24. doi: 10.1016/j.nbd.2010.02.014. Epub 2010 Mar 6.

PMID:
20211261
7.

Inhibition of histone deacetylases in rats self-administering cocaine regulates lissencephaly gene-1 and reelin gene expression, as revealed by microarray technique.

Host L, Anglard P, Romieu P, Thibault C, Dembele D, Aunis D, Zwiller J.

J Neurochem. 2010 Apr;113(1):236-47. doi: 10.1111/j.1471-4159.2010.06591.x. Epub 2010 Feb 2.

8.

Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain.

Cassel S, Carouge D, Gensburger C, Anglard P, Burgun C, Dietrich JB, Aunis D, Zwiller J.

Mol Pharmacol. 2006 Aug;70(2):487-92. Epub 2006 May 2.

PMID:
16670375
9.

Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression.

El Bedoui J, Oak MH, Anglard P, Schini-Kerth VB.

Cardiovasc Res. 2005 Aug 1;67(2):317-25.

PMID:
15885676
10.

Tumor cell-mediated induction of the stromal factor stromelysin-3 requires heterotypic cell contact-dependent activation of specific protein kinase C isoforms.

Louis K, Guérineau N, Fromigué O, Defamie V, Collazos A, Anglard P, Shipp MA, Auberger P, Joubert D, Mari B.

J Biol Chem. 2005 Jan 14;280(2):1272-83. Epub 2004 Oct 27.

11.

Clinicopathological significance of stromelysin-3 expression in colorectal cancer.

Skoglund J, Emterling A, Arbman G, Anglard P, Sun XF.

Oncology. 2004;67(1):67-72.

PMID:
15459498
13.

Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation.

Chavey C, Mari B, Monthouel MN, Bonnafous S, Anglard P, Van Obberghen E, Tartare-Deckert S.

J Biol Chem. 2003 Apr 4;278(14):11888-96. Epub 2003 Jan 15.

14.
15.

Rat liver injury after normothermic ischemia is prevented by a phosphinic matrix metalloproteinase inhibitor.

Cursio R, Mari B, Louis K, Rostagno P, Saint-Paul MC, Giudicelli J, Bottero V, Anglard P, Yiotakis A, Dive V, Gugenheim J, Auberger P.

FASEB J. 2002 Jan;16(1):93-5. Epub 2001 Nov 14.

PMID:
11709491
16.

Transcription regulation and protein subcellular localization of the truncated basic hair keratin hHb1-DeltaN in human breast cancer cells.

Boulay A, Régnier CH, Anglard P, Stoll I, Tomasetto C, Rio MC.

J Biol Chem. 2001 Jun 22;276(25):22954-64. Epub 2001 Apr 13.

18.
19.

[Extracellular proteases of stromal origin: contribution to tumor progression and therapeutic perspectives].

Rio MC, Masson R, Chenard MP, Lefebvre O, Noël A, Anglard P, Bellocq JP, Basset P.

C R Seances Soc Biol Fil. 1998;192(2):253-9. Review. French.

PMID:
9759368
20.

Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression.

Ahmad A, Hanby A, Dublin E, Poulsom R, Smith P, Barnes D, Rubens R, Anglard P, Hart I.

Am J Pathol. 1998 Mar;152(3):721-8.

21.

Modulation of human stromelysin 3 promoter activity and gene expression by human breast cancer cells.

Ahmad A, Marshall JF, Basset P, Anglard P, Hart IR.

Int J Cancer. 1997 Oct 9;73(2):290-6.

22.

Stromelysin-3: a paradigm for stroma-derived factors implicated in carcinoma progression.

Basset P, Bellocq JP, Lefebvre O, Noël A, Chenard MP, Wolf C, Anglard P, Rio MC.

Crit Rev Oncol Hematol. 1997 May;26(1):43-53. Review. No abstract available.

24.

Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications.

Basset P, Okada A, Chenard MP, Kannan R, Stoll I, Anglard P, Bellocq JP, Rio MC.

Matrix Biol. 1997 Mar;15(8-9):535-41. Review.

PMID:
9138286
25.

Characterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmercuric acetate and furin-type convertases.

Santavicca M, Noel A, Angliker H, Stoll I, Segain JP, Anglard P, Chretien M, Seidah N, Basset P.

Biochem J. 1996 May 1;315 ( Pt 3):953-8.

26.

Stromelysin-3 in the biology of the normal and neoplastic mammary gland.

Rio MC, Lefebvre O, Santavicca M, Noël A, Chenard MP, Anglard P, Byrne JA, Okada A, Régnier CH, Masson R, Bellocq JP, Basset P.

J Mammary Gland Biol Neoplasia. 1996 Apr;1(2):231-40. Review.

PMID:
10887496
27.

Stromelysin-3 and other stromelysins in breast cancer: importance of epithelial-stromal interactions during tumor progression.

Basset P, Bellocq JP, Anglard P, Chenard MP, Lefebvre O, Noël A, Okada A, Rouyer N, Santavicca M, Stoll I, Wolf C, Rio MC.

Cancer Treat Res. 1996;83:353-67. Review. No abstract available.

PMID:
8826655
28.

Comparative expression of the psoriasin (S100A7) and S100C genes in breast carcinoma and co-localization to human chromosome 1q21-q22.

Moog-Lutz C, Bouillet P, Régnier CH, Tomasetto C, Mattei MG, Chenard MP, Anglard P, Rio MC, Basset P.

Int J Cancer. 1995 Oct 9;63(2):297-303.

PMID:
7591220
29.

Structure and promoter characterization of the human stromelysin-3 gene.

Anglard P, Melot T, Guérin E, Thomas G, Basset P.

J Biol Chem. 1995 Sep 1;270(35):20337-44.

30.

Expression of nm23 in cell lines derived from patients with metastatic renal cell carcinoma.

Walther MM, Anglard P, Gnarra J, Pozzatti R, Venzon D, de la Rosa A, MacDonald NJ, Steeg PS, Linehan WM.

J Urol. 1995 Jul;154(1):278-82.

PMID:
7776445
31.

Loss of heterozygosity occurs centromeric to RB without associated abnormalities in the retinoblastoma gene in tumors from patients with metastatic renal cell carcinoma.

Walther MM, Gnarra JR, Elwood L, Xu HJ, Florence C, Anglard P, Hu SX, King C, Trahan E, Hurley K, et al.

J Urol. 1995 Jun;153(6):2050-4.

PMID:
7752392
32.

The use of molecular genetic analysis in the diagnosis of renal cell carcinoma.

Long JP, Anglard P, Gnarra JR, Walther MM, Merino MJ, Liu S, Lerman MI, Zbar B, Linehan WM.

World J Urol. 1994;12(2):69-73. Review.

PMID:
7916238
33.

Chromosome 17p deletions and p53 mutations in renal cell carcinoma.

Reiter RE, Anglard P, Liu S, Gnarra JR, Linehan WM.

Cancer Res. 1993 Jul 1;53(13):3092-7.

34.

Molecular genetic studies of sporadic and familial renal cell carcinoma.

Gnarra JR, Glenn GM, Latif F, Anglard P, Lerman MI, Zbar B, Linehan WM.

Urol Clin North Am. 1993 May;20(2):207-16. Review.

PMID:
8098558
35.

Stimulation of glycolysis by corticotropin and phorbol ester in cultured neurons.

Anglard P, Magal E, Louis JC.

Biochim Biophys Acta. 1992 Feb 3;1133(3):321-8.

PMID:
1531303
36.

Molecular and cellular characterization of human renal cell carcinoma cell lines.

Anglard P, Trahan E, Liu S, Latif F, Merino MJ, Lerman MI, Zbar B, Linehan WM.

Cancer Res. 1992 Jan 15;52(2):348-56.

37.

Somatic allelic deletion of nm23 in human cancer.

Leone A, McBride OW, Weston A, Wang MG, Anglard P, Cropp CS, Goepel JR, Lidereau R, Callahan R, Linehan WM, et al.

Cancer Res. 1991 May 1;51(9):2490-3.

38.

Molecular analysis of genetic changes in the origin and development of renal cell carcinoma.

Anglard P, Tory K, Brauch H, Weiss GH, Latif F, Merino MJ, Lerman MI, Zbar B, Linehan WM.

Cancer Res. 1991 Feb 15;51(4):1071-7.

39.

The effect of suramin, tumor necrosis factor and interferon gamma on human prostate carcinoma.

Liu S, Ewing MW, Anglard P, Trahan E, La Rocca RV, Myers CE, Linehan WM.

J Urol. 1991 Feb;145(2):389-92.

PMID:
1899122
40.

Epidermal growth factor receptor gene analysis in renal cell carcinoma.

Gomella LG, Anglard P, Sargent ER, Robertson CN, Kasid A, Linehan WM.

J Urol. 1990 Jan;143(1):191-3.

PMID:
2294252
41.
42.

Southern blot analysis of transformed growth factor alpha and beta DNA in normal kidney and in renal cell carcinoma.

Wade TP, Comelia LG, Sargent ER, Anglard P, Kasid A, Linehan WM.

Curr Surg. 1989 Sep-Oct;46(5):401-3. No abstract available.

PMID:
2805783
43.

Genetic changes in human adrenocortical carcinomas.

Yano T, Linehan M, Anglard P, Lerman MI, Daniel LN, Stein CA, Robertson CN, LaRocca R, Zbar B.

J Natl Cancer Inst. 1989 Apr 5;81(7):518-23. Erratum in: J Natl Cancer Inst 1989 Aug 16;81(16):1263.

PMID:
2564050
44.

Improved detection of allele loss in renal cell carcinomas after removal of leukocytes by immunologic selection.

Linehan M, Miller E, Anglard P, Merino M, Zbar B.

J Natl Cancer Inst. 1989 Feb 15;81(4):287-90.

PMID:
2913326
46.

[Neurotropic action of adrenocorticotropic hormone].

Louis JC, Anglard P, Vincendon G.

Presse Med. 1986 Feb 1;15(4):157-60. Review. French.

PMID:
3008142
47.

Regulation of cyclic AMP and cyclic GMP levels by adrenocorticotropic hormone in cultured neurons.

Anglard P, Zwiller J, Vincendon G, Louis JC.

Biochem Biophys Res Commun. 1985 Nov 27;133(1):286-92.

PMID:
3000376
48.

Regulation of deoxyglucose uptake by adrenocorticotropic hormone in cultured neurons.

Daval JL, Anglard P, Gerard MJ, Vincendon G, Louis JC.

J Cell Physiol. 1985 Jul;124(1):75-80.

PMID:
2995412
49.

Long-term culture of neurones from human cerebral cortex in serum-free medium.

Louis JC, Langley K, Anglard P, Wolf M, Vincendon G.

Neurosci Lett. 1983 Nov 11;41(3):313-9.

PMID:
6363989

Supplemental Content

Loading ...
Support Center